| |
| |
|
| Insider
Information: |
Hoelscher Paul W. |
| Relationship: |
EVP, CFO |
| City: |
Deerfield |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,049 |
|
|
Indirect Shares
|
139,462 |
|
|
| Direct
Value |
$29,687 |
|
|
|
Indirect Value
|
$3,946,775 |
|
|
| Total
Shares |
140,511 |
|
|
| Total
Value |
$3,976,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, CFO |
2022-04-20 |
1,049 |
2022-04-20 |
139,462 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2017-06-23 |
4 |
D |
$11.73 |
$107,212 |
D/D |
(9,140) |
74,995 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2018-03-23 |
4 |
D |
$13.86 |
$190,339 |
D/D |
(13,733) |
92,262 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2018-06-23 |
4 |
D |
$17.67 |
$156,556 |
D/D |
(8,860) |
105,772 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2019-01-05 |
4 |
D |
$20.39 |
$599,853 |
D/D |
(29,419) |
142,048 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2019-02-20 |
4 |
D |
$21.54 |
$690,659 |
D/D |
(32,064) |
182,359 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2019-03-23 |
4 |
D |
$26.84 |
$368,594 |
D/D |
(13,733) |
199,626 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2020-01-05 |
4 |
D |
$36.10 |
$2,502,488 |
D/D |
(69,321) |
226,043 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2020-02-19 |
4 |
D |
$36.06 |
$239,763 |
D/D |
(6,649) |
11,407 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-01-05 |
4 |
D |
$73.28 |
$9,870,669 |
D/D |
(134,698) |
170,181 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-01-21 |
4 |
D |
$77.43 |
$190,633 |
D/D |
(2,462) |
4,143 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-02-17 |
4 |
D |
$87.17 |
$91,093 |
D/D |
(1,045) |
2,362 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-07-28 |
4 |
D |
$102.50 |
$395,445 |
D/D |
(3,858) |
8,261 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-05 |
4 |
D |
$101.84 |
$5,159,825 |
D/D |
(50,666) |
64,580 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-21 |
4 |
D |
$86.42 |
$212,852 |
D/D |
(2,463) |
67,675 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2020-02-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
226,043 |
226,043 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2020-02-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,452 |
237,495 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-01-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
169,132 |
272,057 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-02-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,094 |
275,151 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-08-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
6,163 |
178,389 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
238,852 |
172,226 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2020-02-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
226,043 |
3,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2020-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,452 |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-01-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
169,132 |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,094 |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-08-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,163 |
2,098 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
